Trials / Completed
CompletedNCT01701024
Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne
A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of ACYC and ACYC Vehicle Gel in the Treatment of Acne Vulgaris
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 498 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 12 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to compare the efficacy and safety and tolerability of ACYC Gel and vehicle in the treatment of subjects with Acne Vulgaris.
Detailed description
The primary objective of this study is to compare the efficacy and safety and tolerability of ACYC Gel and vehicle in the treatment of subjects with Acne Vulgaris
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ACYC | ACYC active, topically applied to the face for 12 weeks |
| DRUG | ACYC vehicle | ACYC vehicle (placebo), topically applied to the face for 12 weeks |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-05-01
- Completion
- 2013-07-01
- First posted
- 2012-10-04
- Last updated
- 2018-06-04
- Results posted
- 2017-01-10
Locations
24 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01701024. Inclusion in this directory is not an endorsement.